Simplex Trading
TNYA icon

Simplex Trading’s Tenaya Therapeutics TNYA Stock Holding History

Simplex Trading’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.9K Buy
13,400
+3,800
+40% +$2.88K ﹤0.01% 7699
2026
Q1 		$6.64K Sell
9,600
-22,400
-70% -$16.5K ﹤0.01% 7695
2025
Q4 		$22.8K Buy
32,000
+100
+0.3% +$136 ﹤0.01% 6358
2025
Q3 		$51K Buy
31,900
+20,300
+175% +$20.4K ﹤0.01% 6446
2025
Q2 		$7K Sell
11,600
-800
-6% -$407 ﹤0.01% 7591
2025
Q1 		$7K Sell
12,400
-93,500
-88% -$92.2K ﹤0.01% 7372
2024
Q4 		$151K Buy
+105,900
New +$237K ﹤0.01% 4783
2024
Q3 		– Sell
-11,400
Closed -$35K – 9599
2024
Q2 		$35K Sell
11,400
-6,900
-38% -$28.5K ﹤0.01% 6421
2024
Q1 		$95K Buy
+18,300
New +$87.6K ﹤0.01% 5641
2023
Q4 		– Sell
-12,400
Closed -$31K – 9835
2023
Q3 		$31K Hold
12,400
– – ﹤0.01% 6232
2023
Q2 		$72K Buy
12,400
+5,400
+77% +$31.4K ﹤0.01% 5461
2023
Q1 		$19K Buy
7,000
+700
+11% +$1.97K ﹤0.01% 6976
2022
Q4 		$12K Buy
+6,300
New +$15.4K ﹤0.01% 7398

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading's TNYA Position: Q2 2026 in Review

Simplex Trading reduced its Tenaya Therapeutics (TNYA) stake by 68% in Q2 2026, selling an estimated $26.3K and leaving 16,035 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #7554.

Simplex Trading first reported a position in TNYA in Q3 2022 and has held it in 14 quarters since. The position peaked at $181K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Simplex Trading held 16,035 shares of Tenaya Therapeutics worth $11.8K as of Q2 2026.
  • Simplex Trading sold 34,620 Tenaya Therapeutics shares in Q2 2026, an estimated $26.3K.
  • Tenaya Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7554 holding.
  • Simplex Trading first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 14 quarters since.
  • Simplex Trading's Tenaya Therapeutics position peaked at $181K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.